-
-
公开(公告)号：US20240245735A1
公开(公告)日：2024-07-25
申请号：US18364151
申请日：2023-08-02
发明人： Heli Putaala , Sofia Forssten , Sampo Lahtinen , Arthur Ouwehand , Jaana Mättö , Harri Mäkivuokko , Janne Nikkilä
IPC分类号： A61K35/747 , A23L33/00 , A23L33/135 , A61K35/745 , A61P1/04 , A61P1/12 , A61P1/14
CPC分类号： A61K35/747 , A23L33/135 , A23L33/30 , A61K35/745 , A61P1/04 , A61P1/12 , A61P1/14
摘要： The present invention relates to bacteria and metabolites thereof that are capable of binding to A, B and/or O blood type antigens or which are acid and/or bile tolerant, their use in probiotic compositions and food products, and methods for their selection. The invention also relates to the use of said bacteria and metabolites for the prevention and/or treatment of gastrointestinal disorders.
-
公开(公告)号：US20240215610A1
公开(公告)日：2024-07-04
申请号：US18563099
申请日：2022-05-25
发明人： THERESE FJAEREIDE , DORTHE STENBAEK , CASPER LUND , SANTIAGO SOLORIO , TORBEN SNABE , KHAMFA PHONCHAREON , ULRIK KOFOD MADSEN , ROBIN KAY CONNELLY
IPC分类号： A23J3/16 , A23J3/22 , A23J3/26 , A23L29/212 , A23L29/256 , A23P30/20
CPC分类号： A23J3/16 , A23J3/227 , A23J3/26 , A23L29/212 , A23L29/256 , A23P30/20
摘要： This disclosure relates to an extrudate which contains, by weight based on the weight of the extrudate on a moisture-free basis, (a) from about 60% to about 90% plant protein; (b) from about 1% to about 10% hydrocolloid, wherein the hydrocolloid is selected from the group consisting of alginate, pectin, agar, methylcellulose, and mixtures thereof; and (c) optionally, no more than about 14% starch. This disclosure also relates to a dry-blend composition which contains, by weight based on the total weight of the dry-blend composition on a moisture-free basis, (a) from about 65% to about 98% plant protein material, (b) from about 1% to about 10% hydrocolloid, wherein the hydrocolloid is selected from the group consisting of alginate, pectin, agar, methylcellulose, and mixtures thereof; and (c) optionally, no more than about 14% starch.
-
公开(公告)号：US20240124857A1
公开(公告)日：2024-04-18
申请号：US18277440
申请日：2022-02-18
IPC分类号： C12N9/16 , A61K35/745
CPC分类号： C12N9/16 , A61K35/745 , C12Y301/03002
摘要： Provided herein, inter alia, are compositions and methods for treating and/or preventing conditions associated with gut inflammation caused by dysbiosis via use of exogenously administered acid phosphatases or enzymes of the GDA1_CD39 superfamily (such as apyrases).
-
公开(公告)号：US20240117271A1
公开(公告)日：2024-04-11
申请号：US18255924
申请日：2021-12-02
发明人： Rasmus Leth Miller
CPC分类号： C11D1/04 , C11D3/43 , C11D11/0094 , C11D17/0008
摘要： The present invention relates to a liquid DATEM composition comprising DATEM rich in DATEM I and/to DATEM II, and a diluent selected from the group consisting of water, glycerol and mixtures thereof. The invention is also related to a process for preparing the composition and the use thereof.
-
公开(公告)号：US20240115630A1
公开(公告)日：2024-04-11
申请号：US18317443
申请日：2023-05-15
发明人： Lotta Stenman , Sampo Lahtinen
IPC分类号： A61K35/745 , A23L33/00 , A23L33/135 , A23L33/26 , A61K47/36 , A61P3/00 , C12N1/20
CPC分类号： A61K35/745 , A23L33/135 , A23L33/26 , A23L33/30 , A61K47/36 , A61P3/00 , C12N1/20 , C12N1/205 , A23V2002/00 , A23V2200/3204 , A23V2200/332 , C12R2001/01
摘要： This invention relates to the use of a bacterium of the genus Bifidobacterium, particularly, but not exclusively, a bacterium of the Bifidobacterium animalis ssp. lactis strain 420 (B420) for use in reducing food, energy and/or fat intake.
-
公开(公告)号：US20240108668A1
公开(公告)日：2024-04-04
申请号：US18257612
申请日：2021-12-13
发明人： Maija Emilia Marttinen , Markku Saarinen , Arja Laitila , Paivi Nurminen , Markus Lehtinen , Mehreen Anjum
IPC分类号： A61K35/747 , A23L33/135 , A23L33/185 , A61K35/744 , A61K35/745 , A61P1/14
CPC分类号： A61K35/747 , A23L33/135 , A23L33/185 , A61K35/744 , A61K35/745 , A61P1/14 , A23V2400/113 , A23V2400/231 , A23V2400/531 , A61K2035/115
摘要： This invention relates to the use of bacterial strains for improving protein digestion and/or increasing amino acid bioavailability in a subject, wherein said bacterial strains are of the species Bifidobacterium animalis subsp. lactis, Lacticaseibacillus paracasei, Lactococcus lactis, Lactobacillus acidophilus, Lactiplantibacillus plantarum and/or Lacticaseibacillus rhamnosus or a mixture thereof.
-
公开(公告)号：US20240108021A1
公开(公告)日：2024-04-04
申请号：US18474373
申请日：2023-09-26
发明人： Karina Hansen Kjaer , Slavko Kralj
CPC分类号： A23C9/1216 , A23C9/1307 , A23G9/34 , A23G9/363 , A23L27/36 , C12P19/18 , C12P19/56
摘要： Disclosed herein are methods of glucosylating a steviol glycoside. These methods can comprise providing a composition that comprises at least (i) water, (ii) sucrose, (iii) stevioside or rebaudioside A, and (iv) a glucosyltransferase enzyme that synthesizes alpha-1,6-glucan or a glucosyltransferase enzyme that synthesizes alpha-1,3-glucan, wherein at least one glucosylated form of the stevioside or rebaudioside A is produced in the composition. Such a composition can be a food product/precursor, for instance.
-
公开(公告)号：US20240041953A1
公开(公告)日：2024-02-08
申请号：US18194313
申请日：2023-03-31
发明人： Lotta Stenman , Sampo Lahtinen , John Konhilas
IPC分类号： A61K35/747 , A23L33/135 , A61K35/74 , A61P9/10
CPC分类号： A61K35/747 , A23L33/135 , A61K35/74 , A61P9/10 , A23V2002/00 , A23V2400/181 , A23V2200/326
摘要： The use of a bacterium of the species Lactobacillus salivarius in the manufacture of a food product, dietary supplement or medicament for treating cardiac dysfunction, particularly myocardial infarction, congestive heart failure, dilated cardiomyopathy or inflammatory heart disease (including endocarditis, inflammatory cardiomegaly and myocarditis) is disclosed.
-
10.发明授权公开(公告)号：US11883446B2
公开(公告)日：2024-01-30
申请号：US17711081
申请日：2022-04-01
发明人： Sebastien Guery , Markus Lehtinen , Sinikka Anneli Latvala , Liisa Lehtoranta , Bryan-James Zabel , Wesley William Morovic , Charles Budinoff , Scott D. Power
IPC分类号： A61K35/745 , A61P31/14 , A61K35/744
CPC分类号： A61K35/745 , A61K35/744 , A61P31/14
摘要： This invention relates to bacterial strains, compositions comprising bacterial strains as well as methods and uses of said strains and compositions for preventing or treating illness and/or symptoms associated with a coronavirus in a subject in need thereof.
-
-
-
-
-
-
-
-
-
搜索结果
337 条记录 (耗时 0.041 秒)
